Your browser doesn't support javascript.
loading
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Rollier, Christine S; Dold, Christina; Blackwell, Luke; Linder, Aline; Silva-Reyes, Laura; Clutterbuck, Elizabeth; Davis, Kimberly; Ford, Karen; Liu, Xinxue; Holland, Ann; Chan, Hannah; Harbinson, Holly; O'Connor, Daniel; Borrow, Ray; Snape, Matthew D; Pollard, Andrew J.
Affiliation
  • Rollier CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK. Electronic address: c.rollier@surrey.ac.uk.
  • Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Blackwell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Linder A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Clutterbuck E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Davis K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Ford K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Holland A; UK Health Security Agency, Vaccine Evaluation Unit, Manchester Royal Infirmary, M13 9WL Manchester, UK.
  • Chan H; UK Health Security Agency, Vaccine Evaluation Unit, Manchester Royal Infirmary, M13 9WL Manchester, UK.
  • Harbinson H; UK Health Security Agency, Vaccine Evaluation Unit, Manchester Royal Infirmary, M13 9WL Manchester, UK.
  • O'Connor D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Borrow R; UK Health Security Agency, Vaccine Evaluation Unit, Manchester Royal Infirmary, M13 9WL Manchester, UK.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX37LE, UK.
Vaccine ; 40(32): 4453-4463, 2022 07 30.
Article in En | MEDLINE | ID: mdl-35697571
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Immunogenicity, Vaccine Type of study: Clinical_trials Limits: Adolescent / Child / Humans Language: En Journal: Vaccine Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Immunogenicity, Vaccine Type of study: Clinical_trials Limits: Adolescent / Child / Humans Language: En Journal: Vaccine Year: 2022 Type: Article